Megna Michael R (CIK 0001464583)

Latest company ownership

KNSA - Kiniksa Pharmaceuticals International, plc
Role: CHIEF ACCOUNTING OFFICER
Shares held
12,787
Last filed at
Oct 22, 2025
Confidence Score
3.1
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 20, 2025 Oct 22, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 5.0 -50,490 -65.12% ✓ $2M
Oct 4, 2025 Oct 8, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 45.0 -85 -0.22% ✗ $3.3K
Sep 1, 2025 Sep 3, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 22.5 -15,657 -12.11% ✓ $539.5K
Jul 15, 2025 Aug 6, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 17.5 -16,505 -19.98% ✓ $550K
Jun 3, 2025 Jun 5, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 7.5 -15,211 -31.85% ✓ $437.3K
May 7, 2025 May 9, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 7.5 -17,647 -35.16% ✓ $471K
Apr 7, 2025 Apr 9, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -1,666 -4.87% ✗ $33.8K
Apr 1, 2025 Apr 3, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -2,084 -6.44% ✗ $45.4K
Jan 15, 2025 Mar 19, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 60.0 +141 0.26% ✗ $7.4K
Mar 12, 2025 Mar 14, 2025 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 10.0 -9,051 -25.44% ✓ $203.2K
Nov 27, 2024 Dec 2, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 25.0 -8,646 -14.01% ✓ $194.1K
Oct 4, 2024 Oct 8, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 45.0 -82 -0.31% ✗ $2K
Jul 15, 2024 Sep 4, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 22.5 -2,604 -3.37% ✗ $82.5K
Apr 8, 2024 Apr 8, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -1,666 -7.25% ✗ $29.8K
Apr 1, 2024 Apr 3, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -1,084 -5.38% ✗ $21.4K
Jan 15, 2024 Mar 1, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 12.5 -14,202 -21.21% ✓ $318.9K
Jan 2, 2024 Jan 4, 2024 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 7.5 -16,670 -49.50% ✓ $319.6K
Dec 19, 2023 Dec 21, 2023 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 10.0 -9,316 -35.39% ✓ $178.2K
Oct 4, 2023 Oct 6, 2023 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 45.0 -52 -0.30% ✗ $832.5
Jul 15, 2023 Sep 6, 2023 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -802 -1.69% ✗ $24.6K
Apr 10, 2023 Apr 11, 2023 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -1,155 -8.17% ✗ $12.4K
Jan 15, 2023 Mar 20, 2023 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 37.5 -152 -0.56% ✗ $9.6K
Oct 4, 2022 Oct 6, 2022 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 37.5 -52 -0.70% ✗ $740
Jul 15, 2022 Sep 6, 2022 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 82.5 +475 3.50% ✗ $2.6K
Mar 21, 2022 Mar 23, 2022 Kiniksa Pharmaceuticals International, plc CHIEF ACCOUNTING OFFICER Sell 26.3 -1,120 -15.64% ✗ $12.3K
Jun 30, 2020 Mar 18, 2022 Kiniksa Pharmaceuticals International, plc Chief Accounting Officer Sell 90.0 +2,018 16.72% ✗ $2.7K